Atlas Trials

Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment

Clinical trial NCT04302402 · UNKNOWN

Trial details

NCT number
NCT04302402
Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Dyspepsia
Start date
2020-03-01
Primary completion
2021-03-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.